Please try another search
For the three months ended 31 March 2017, Farmacol SA revenues increased 3% to PLN1.62B. Net income decreased 58% to PLN19.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Gain/Sale of Fixed Assets decrease of 100% to PLN75K (income), Administrative Cost increase from PLN11.4M to PLN46.6M (expense), Interest Expense increase of 30% to PLN194K (expense).
Period Ending: | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 |
---|---|---|---|---|
Total Revenue | 1623.97 | 1487.43 | 1483.18 | 1495.13 |
Gross Profit | 104.9 | 74.95 | 102.36 | 109.89 |
Operating Income | 15.3 | 34.75 | 21.5 | 27.59 |
Net Income | 19.48 | 34.08 | 21.95 | 25.79 |
Period Ending: | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 |
---|---|---|---|---|
Total Assets | 2898.44 | 2829.2 | 2670.23 | 2599.84 |
Total Liabilities | 1512.6 | 1462.86 | 1337.99 | 1289.51 |
Total Equity | 1385.84 | 1366.34 | 1332.24 | 1310.33 |
Period Ending: | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | 29.3 | 169.12 | 52.11 | 62.98 |
Cash From Investing Activities | -129.01 | -231.29 | 195.29 | 243.66 |
Cash From Financing Activities | 91.71 | -42.52 | -41.13 | -39.52 |
Net Change in Cash | -8 | -104.69 | 206.27 | 267.13 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review